LXRX vs ANRO
Comparison between Lexicon Pharmaceuticals Inc (LXRX, Company) and Alto Neuroscience Inc (ANRO, Company).
Both LXRX and ANRO are from the Healthcare sector.
LXRX vs ANRO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
LXRX
$958M
ANRO
$954M
Max Drawdown
LXRX
99.91%
Winner
ANRO
91.74%
Sharpe Ratio
LXRX
1.15
Winner
ANRO
2.20
5Y Beta
Winner
LXRX
1.08
ANRO
1.27
Industry
LXRX
Biotechnology
ANRO
Biotechnology
P/E Ratio
Winner
LXRX
-31.76
ANRO
-11.20
PEG Ratio
LXRX
-0.14
Winner
ANRO
-2.89
Debt to Equity
LXRX
24.49%
Winner
ANRO
6.58%
Free Cash Flow Yield
Winner
LXRX
-4.05%
ANRO
-6.59%
P/S Ratio
LXRX
15.18
ANRO
N/A
P/B Ratio
LXRX
5.10
Winner
ANRO
4.32
LXRX vs ANRO - Historical Returns
Returns include dividend reinvestment.
1M
LXRX
+3.15%
Winner
ANRO
+7.47%
3M
Winner
LXRX
+36.31%
ANRO
+9.18%
6M
LXRX
+34.71%
Winner
ANRO
+61.17%
1Y
LXRX
+102.65%
Winner
ANRO
+769.16%
5Y(CAGR)
LXRX
-7.60%
ANRO
N/A
10Y(CAGR)
LXRX
-17.59%
ANRO
N/A
Max(CAGR)
LXRX
-14.27%
Winner
ANRO
+10.96%
LXRX vs ANRO - Annual Returns (2000 - 2026)
Returns include dividend reinvestment.
| Year | LXRX | ANRO |
|---|---|---|
| 2026 | +100.88% | +61.36% |
| 2025 | +47.99% | +306.39% |
| 2024 | -53.55% | -79.57% |
| 2023 | -23.12% | N/A |
| 2022 | -50.90% | N/A |
| 2021 | +11.93% | N/A |
| 2020 | -16.38% | N/A |
| 2019 | -39.94% | N/A |
| 2018 | -34.39% | N/A |
| 2017 | -30.42% | N/A |
| 2016 | +5.17% | N/A |
| 2015 | +105.98% | N/A |
| 2014 | -49.17% | N/A |
| 2013 | -24.41% | N/A |
| 2012 | +76.80% | N/A |
| 2011 | -14.00% | N/A |
| 2010 | -16.76% | N/A |
| 2009 | +18.06% | N/A |
| 2008 | -54.10% | N/A |
| 2007 | -17.89% | N/A |
| 2006 | -5.25% | N/A |
| 2005 | -50.68% | N/A |
| 2004 | +28.18% | N/A |
| 2003 | +14.37% | N/A |
| 2002 | -57.69% | N/A |
| 2001 | -17.57% | N/A |
| 2000 | -11.31% | N/A |
LXRX vs ANRO Drawdown Comparison
The maximum drawdown for LXRX was -99.91%, occurring on Mar 3, 2025. This drawdown has not yet recovered.
The maximum drawdown for ANRO was -91.74%, occurring on Apr 4, 2025. Recovery took 523 trading sessions.
The current LXRX drawdown is -99.31%. The current ANRO drawdown is -4.63%.
| Rank | LXRX | ANRO |
|---|---|---|
| #1 | -99.91% Jul 21, 2000 - Mar 3, 2025 | -91.74% Feb 5, 2024 - Mar 9, 2026 |
| #2 | -51.33% Apr 7, 2000 - Jun 20, 2000 | -34.20% Apr 17, 2026 - Jun 29, 2026 |
| #3 | -15.33% Jul 10, 2000 - Jul 20, 2000 | -17.74% Mar 16, 2026 - Apr 13, 2026 |
| #4 | -8.08% Jun 21, 2000 - Jun 23, 2000 | -11.72% Jun 29, 2026 - Jul 2, 2026 |
| #5 | -5.17% Jun 28, 2000 - Jul 5, 2000 | -5.05% Mar 9, 2026 - Mar 11, 2026 |
| #6 | N/A | -3.56% Mar 11, 2026 - Mar 16, 2026 |
| #7 | N/A | -1.36% Apr 14, 2026 - Apr 16, 2026 |
Correlation
Correlation between LXRX and ANRO is 0.68 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.68
-101
Select Stocks to Compare
Popular: LXRX vs SPYANRO vs SPY
More Comparisons
Compare with similar stocks